Resilinc
SEPTEMBER 12, 2023
Supply chain shortages have led to frustration at the pharmacy counter for many this year. With critical cancer drug shortages in May and ADHD medication shortages continuing even into Fall 2023, it has been difficult for many to get the pharmaceuticals they need. What is the Drug Supply Chain Security Act (DSCSA)?
The Network Effect
AUGUST 26, 2014
Due to more complex supply chains, policy makers worldwide are enforcing stricter regulations for manufacturing and logistics. In the years to come, the FDA expects domestic GMP inspections to decrease and more inspections in the foreign arena (FDA 2013) reflecting the trend towards more globalized supply chains.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Network Effect
JULY 29, 2014
Today is the first in a series of posts that explores what are in my opinion the ten most significant trends that are transforming the pharmaceutical supply chain. The market for Over-the-Counter (OTC) medicines is now forecast to outgrow the total current pharmaceutical market. pharmaceutical supply network.
QAD
AUGUST 18, 2022
Pharmaceutical manufacturers and their supply, contract packaging and distribution partners are under constant pressure to comply with government requirements while maintaining high standards for patient safety, product quality and innovation. What is the Drug Supply Chain Security Act (DSCSA)? consumers.”.
Elementum
NOVEMBER 16, 2016
government is making a big push for pharma traceability, hoping to quell the amount of counterfeit drugs imported into the country. But that’s no easy feat in such a huge supply chain. The pharmaceutical industry is continuously facing the challenge of balancing expenditures and returns. by 2020 , with a 3.5%
Supply Chain Movement
MARCH 20, 2014
4th Annual Pharmaceutical Logistics & Cold Chain Forum. JOIN THE PHARMACEUTICAL LOGISTICS & COLD CHAIN FORUM. Senior Manager Plasma Logistics & Dispositioning. International Supply Chain Lead, Global Commercial Supply Chain. Supply Chain Optimization.
Kinaxis
APRIL 4, 2019
by Bill DuBois The life sciences supply chain starts with a miracle. In a recent Forbes interview on why it’s so hard to bring tech into pharma, Vas Narasimhan, Chief Executive Officer of Novartis AG pointed out that only one in twenty drugs make it out of clinical trials. Is there a more challenging industry than life sciences?
Expert insights. Personalized for you.
58 
Let's personalize your content